Home / Recalls / Pacifico National, Inc. dba AmEx Pharmacy / D-1850-2019

D-1850-2019 Class II Terminated

Recalled by Pacifico National, Inc. dba AmEx Pharmacy — Melbourne, FL

Recall Details

Product Type
Drugs
Report Date
September 18, 2019
Initiation Date
August 30, 2019
Termination Date
October 8, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity

Product Description

Bevacizumab, 1.25 mg/0.05 mL, 31G MJ Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901

Reason for Recall

Lack of assurance of sterility.

Distribution Pattern

Continental U.S. and Puerto Rico

Code Information

All lots remaining within expiry.

Other recalls by Pacifico National, Inc. dba AmEx Pharmacy

  • D-1849-2019 Class II — Bevacizumab, 2.5 mg/0.1 mL, Norm-Ject Syringe Intravitreal Injection, Single use (August 30, 2019)
  • D-1271-2019 Class II — BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologi (April 19, 2019)
  • D-0869-2016 Class I — Avastin (Bevacizumab) 2 mg/0.08 mL syringe, Office Administration Only, AmEx Pha (January 20, 2015)
  • D-0870-2016 Class I — Avastin (Bevacizumab) 1.25 mg/0.05 mL syringe, Office Administration Only, AmEx (January 20, 2015)